Zsuzsanna T. Varga, Ph.D.

2012 Microbiology Mount Sinai School of Medicine, New York, NY 
Virology Biology, Microbiology Biology
"Zsuzsanna Varga"


Sign in to add mentor
Peter Palese grad student 2012 Mount Sinai
 (The Interferon Antagonist Function of the Influenza Virus PB1-F2 Protein.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Burkhard-Koren NM, Haberecker M, Maccio U, et al. (2020) Higher prevalence of pulmonary macrothrombi in SARS-CoV-2 than in influenza A: autopsy results from 'Spanish flu' 1918/1919 in Switzerland to Coronavirus disease 2019. The Journal of Pathology. Clinical Research
Varga ZT, Grant A, Manicassamy B, et al. (2012) Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential. Journal of Virology. 86: 8359-66
Varga ZT, Palese P. (2011) The influenza A virus protein PB1-F2: killing two birds with one stone? Virulence. 2: 542-6
Schmolke M, Manicassamy B, Pena L, et al. (2011) Differential contribution of PB1-F2 to the virulence of highly pathogenic H5N1 influenza A virus in mammalian and avian species. Plos Pathogens. 7: e1002186
Varga ZT, Ramos I, Hai R, et al. (2011) The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. Plos Pathogens. 7: e1002067
Conenello GM, Tisoncik JR, Rosenzweig E, et al. (2011) A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivo. Journal of Virology. 85: 652-62
Hai R, Schmolke M, Varga ZT, et al. (2010) PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models. Journal of Virology. 84: 4442-50
See more...